+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Development and validation of an NMR-based identity assay for bacterial polysaccharides



Development and validation of an NMR-based identity assay for bacterial polysaccharides



Analytical Biochemistry 279(2): 226-240



A method utilizing NMR spectroscopy has been developed to confirm the identity of bacterial polysaccharides used to formulate a polyvalent pneumococcal polysaccharide vaccine. The method is based on 600 MHz proton NMR spectra of individual serotype-specific polysaccharides. A portion of the anomeric region of each spectrum (5.89 to 4.64 ppm) is compared to spectra generated for designated reference samples for each polysaccharide of interest. The selected region offers a spectral window that is unique to a given polysaccharide and is sensitive to any structural alteration of the repeating units. The similarity of any two spectral profiles is evaluated using a correlation coefficient (rho), where rho >/= 0.95 between a sample and reference profile indicates a positive identification of the sample polysaccharide. This method has been shown to be extremely selective in its ability to discriminate between serotype-specific polysaccharides, some of which differ by no more than a single glycosidic linkage. Furthermore, the method is rapid and does not require extensive sample manipulations or pretreatments. The method was validated as a qualitative identity assay and will be incorporated into routine quality control testing of polysaccharide powders to be used in preparation of the polyvalent pneumococcal vaccine PNEUMOVAX 23. The specificity and reproducibility of the NMR-based identity assay is superior to the currently used colorimetric assays and can be readily adapted for use with other bacterial polysaccharide preparations as well.

(PDF emailed within 0-6 h: $19.90)

Accession: 010446596

Download citation: RISBibTeXText

PMID: 10706792

DOI: 10.1006/abio.1999.4470


Related references

Development and Validation of a Multiplex PCR-Based Assay for the Upper Respiratory Tract Bacterial Pathogens Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. Molecular Diagnosis 1(1): 29-39, 1996

Development and validation of a PCR-based assay for the quantification of human cytomegalovirus DNA in samples of frozen whole blood, plasma, urine and semen and the employment of the assay in the development of the HCMV inhibitor 1263W94. Antiviral Research 46(1): A80, April, 2000

Exploring the Group B Streptococcus capsular polysaccharides: the structural diversity provides the basis for development of NMR-based identity assays. Journal of Pharmaceutical and Biomedical Analysis 98: 9-15, 2015

Development and validation of a generic fluorescent methyltransferase activity assay based on the transcreener AMP/GMP assay. Journal of Biomolecular Screening 17(1): 59-70, 2012

Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis. Journal of Clinical Microbiology 50(7): 2321-2329, 2012

Development and validation of the Self-Identity Inventory (SII): a multicultural identity development instrument. Cultural Diversity and Ethnic Minority Psychology 6(2): 168-182, 2000

Development and validation of the spiral Salmonella assay: an automated approach to bacterial mutagenicity testing. Mutation Research 223(1): 49-64, 1989

Use and validation of NMR assays for the identity and O-acetyl content of capsular polysaccharides from Neisseria meningitidis used in vaccine manufacture. Journal of Pharmaceutical & Biomedical Analysis 30(4): 1233-1247, 7 November, 2002

Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth media. Journal of Pharmaceutical and Biomedical Analysis 92: 177-182, 2014

Development and Validation of a Highly Accurate Quantitative Real-Time PCR Assay for Diagnosis of Bacterial Vaginosis. Journal of Clinical Microbiology 54(4): 1017-1024, 2016

Validation for high-throughput screening of a VanRS-based reporter gene assay for bacterial cell wall inhibitors. Journal of Applied Microbiology 103(1): 133-140, 2007

Development and validation of a new HPV genotyping assay based on next-generation sequencing. American Journal of Clinical Pathology 141(6): 796-804, 2014

Development and validation of a novel SPR-based assay principle for bispecific molecules. Journal of Pharmaceutical and Biomedical Analysis 102: 144-149, 2015

Development and validation of a cytokine-based assay for the measurement of human LTC-IC. Experimental Hematology (Charlottesville) 23(8): 818, 1995